Liver Cancer (Official Journal)

OFFICIAL JOURNAL

Liver Cancer

Official Journal of the APPLE Association

Liver Cancer is an international peer-reviewed journal committed to advancing liver cancer research and improving patient care through high-quality scientific publications.

Research · Clinical Practice · Global Collaboration

Bibliographic Details

  • Journal Abbreviation: Liver Cancer
  • ISSN: 2235-1795 (Print)
  • e-ISSN: 1664-5553 (Online)
  • DOI: 10.1159/issn.1664-5553
karger.com/LIC

Open Access

All articles published since 2020 are fully Open Access under Creative Commons licenses. Articles published before 2020 remain available through the subscription model. All rights reserved.

Journal Metrics

Impact Factor: 10.5 (Q1 – Oncology – SCIE)
CiteScore: 17.0
Avg. Time to Final Decision: 5 weeks

Indexing & Abstracting

PubMed | US National Library of Medicine
PubMed Central | US National Library of Medicine
Web of Science | Clarivate Analytics
Science Citation Index Expanded | Clarivate Analytics
Google Scholar | Google DOAJ: Directory of Open Access Journals
Chemical Abstracts Service | American Chemical Society
Scopus | Elsevier
Embase | Elsevier
Pathway Studio | Elsevier
WorldCat | OCLC
GoOA | Chinese Academy of Sciences

Advancing Liver Cancer
Research and Care

Liver Cancer connects leading researchers, clinicians and specialists from around the world to share new discoveries and clinical knowledge.

The journal supports the development of evidence-based treatment strategies and promotes academic exchange across diverse disciplines.

VISIT JOURNAL
Liver Cancer Journal Cover

Calls for Papers

See the latest calls for papers from our extensive journal range.

CHECK OUT NOW

Editorial Board

EDITORIAL LEADERSHIP

Editorial Board

The Editorial Board of Liver Cancer brings together leading experts and global leaders in hepatology, oncology and multidisciplinary liver cancer care.

The board supports the journal’s academic excellence by guiding editorial policy, ensuring rigorous peer review and advancing the dissemination of high-impact research.

Editor-in-Chief

Masatoshi Kudo

Kindai University, Osaka, Japan

Associate Editors

Stephen L. Chan

The Chinese University of Hong Kong

Hong Kong, China

Pei-Jer Chen

National Taiwan University Hospital

Taipei, Taiwan

Ann-Lii Cheng

National Taiwan University Hospital

Taipei, Taiwan

Valerie Chew

Duke-NUS Medical School

Singapore City, Singapore

Pierce Chow

Duke-NUS Medical School Singapore

Singapore, Singapore

Laura Dawson

University of Toronto

Toronto, ON, Canada

Jia Fan

Fudan University

Shanghai, China

Edoardo Giannini

University of Genoa

Genoa, Italy

Etsuro Hatano

Kyoto University

Kyoto, Japan

Yujin Hoshida

The University of Texas

Dallas, TX, USA

Kwang-Hyub Han

Yonsei University College of Medicine

Seoul, Korea

Cher Heng Tan

Lee Kong Chian School of Medicine

Singapore City, Singapore

Namiki Izumi

Musashino Red Cross Hospital

Tokyo, Japan

Norihiro Kokudo

National Center for Global Health and Medicine

Tokyo, Japan

Riccardo Lencioni

Pisa University School of Medicine

Pisa, Italy

Tim Meyer

University College London

London, UK

Jeong Min Lee

Seoul National University College of Medicine

Seoul, Korea

Young Nyun Park

Yonsei University College of Medicine

Seoul, Republic of Korea

Markus Peck-Radosavljevic

Klinikum Klagenfurt am Wörthersee

Klagenfurt am Wörthersee, Austria

Jens Ricke

Ludwig-Maximilians-Universität München

Munich, Germany

Lorenza Rimassa

Humanitas University

Milan, Italy

Lewis R. Roberts

Mayo Clinic

Rochester, MN, USA

Michiie Sakamoto

Keio University

Tokyo, Japan

Myron Schwartz

The Mount Sinai Medical Center

New York, USA

Jean Nicolas Vauthey

University of Texas

Houston, TX, USA

Alessandro Vitale

Università di Padova

Padua, Italy

Arndt Vogel

Hannover Medical School

Hannover, Germany

Sheng-Long Ye

Fudan University

Shanghai, China

Andrew X. Zhu

Jiahui International Cancer Center

Shanghai, China

Editorial Board Members

Jacques Belghiti

Beaujon Hospital, Clichy, France

See Ching Chan

Queen Mary Hospital University, Hong Kong, China

Laura Crocetti

University of Pisa, Pisa, Italy

Alessandro Cucchetti

University of Bologna, Bologna, Italy

Richard S. Finn

University of California at Los Angeles, Santa Monica, CA, USA

Francesca Fornari

University of Bologna, Bologna, Italy

Junji Furuse

Kanagawa Cancer Center, Yokohama, Japan

Liana Gheorghe

Fundeni Clinical Institute, Bucharest, Romania

Kiyoshi Hasegawa

The University of Tokyo, Tokyo, Japan

Massimo Iavarone

University of Milan, Milan, Italy

Masafumi Ikeda

National Cancer Center Hospital East, Kashiwa, Japan

Yasuharu Imai

Ikeda Municipal Hospital, Osaka, Japan

Aparna Kalyan

Northwestern University, Chicago, IL, USA

Masayuki Kanematsu

Gifu University Hospital, Gifu, Japan

Xiao-Jie Lu

Nanjing Medical University, Nanjing, China

Irene Oi-lin Ng

The University of Hong Kong, Hong Kong, China

Naoshi Nishida

Kindai University, Osaka, Japan

Kazuhiro Nouso

Okayama University, Okayama, Japan

Fabio Piscaglia

University of Bologna, Bologna, Italy

Toshiharu Sakurai

Kindai University, Osaka, Japan

Peter Schemmer

Visceral Surgery Bern & Pancreas Clinic Switzerland & Liver Clinic Switzerland, Bern, Switzerland

Jinsil Seong

Yonsei University, Seoul, Korea

Wolfgang Sieghart

Medical University of Vienna, Vienna, Austria

Ryosuke Tateishi

The University of Tokyo, Tokyo, Japan

Guido Torzilli

Humanitas University, Milan, Italy

Kaoru Tsuchiya

Musashino Red Cross Hospital, Tokyo, Japan

Kazuomi Ueshima

Kindai University, Osaka, Japan

Maria Varela

Hospital Universitario Central de Asturias, Oviedo, Spain

Chris Verslype

University of Leuven, Leuven, Belgium

Arndt Weinmann

Johannes Gutenberg University, Mainz, Germany

Tatsuya Yamashita

Kanazawa University Hospital, Kanazawa, Japan

Advancing Liver Cancer Research Together

Through global collaboration and academic leadership, we aim to improve outcomes for patients worldwide.

LEARN MORE ABOUT THE JOURNAL

Author Guidelines

FOR AUTHORS

Author Guidelines

Before submitting your manuscript, please review the key information below to ensure your submission meets the journal's editorial and publication requirements. Detailed instructions for each section are available on the following pages.

Journal Scope

Liver Cancer publishes high-quality clinical, translational, and basic research that advances the understanding, diagnosis, prevention, and treatment of liver cancer.

The journal welcomes contributions from researchers and clinicians worldwide.

Before You Submit

Before submitting your manuscript, please make sure that:

  • Your manuscript fits the journal's aims and scope.
  • You have selected the appropriate article type.
  • All authors meet the authorship requirements.
  • Ethical approval and patient consent have been obtained where applicable.
  • Conflicts of interest, funding information, and data availability statements are prepared.
  • The manuscript follows the required formatting and reporting guidelines.

Article Types

The journal accepts several manuscript categories, including:

  • Research Articles
  • Review Articles
  • Systematic Reviews
  • Brief Reports
  • Guidelines
  • Letters
  • Editorials

Each article type includes its own recommended structure, formatting guidance, and downloadable template.

Manuscript Preparation

Authors should prepare their manuscripts using the appropriate journal template and follow the required format for:

  • Title page
  • Abstract and keywords
  • Main text
  • References
  • Tables and figures
  • Supplementary materials
  • Graphical abstracts
  • Plain language summaries (where applicable)

Editorial & Ethical Policies

The journal follows international publishing standards and ethical guidelines.

Authors are expected to comply with policies regarding:

  • Research ethics
  • Human and animal studies
  • Authorship
  • Conflicts of interest
  • Data sharing
  • Publication ethics
  • Use of Generative AI
  • Plagiarism and research integrity

Peer Review

All eligible submissions undergo a rigorous single-anonymous peer review conducted by independent experts to ensure scientific quality, originality, and clinical relevance.

Most manuscripts are evaluated by at least two reviewers before an editorial decision is made.

Submission

Manuscripts should be submitted through the online submission system together with:

  • Cover Letter
  • Required declarations
  • Reporting checklists (when applicable)
  • Supplementary files

Authors can monitor the progress of their manuscript throughout the review process.

Publication Costs

Information regarding Article Processing Charges (APCs), publication support, and supplementary material fees is available before submission.

After Acceptance

Following acceptance, manuscripts proceed through:

  • Copyediting
  • Author proof review
  • DOI assignment
  • Online First publication
  • Final publication and archiving

Articles are published under the journal's licensing and copyright policies.

Need More Information?

Please refer to the detailed Author Guidelines for complete instructions on manuscript preparation, submission requirements, and editorial policies.

Together with the APPLE Association

The Asia-Pacific Primary Liver Cancer Expert Association (APPLE)
#402, GIFC, 240, Kintex-ro, Ilsanseo-gu, Goyang-si, Gyeonggi-do, Korea 10391
Tel: 82-2-373-1005 Fax: 82-2-373-1106
E-mail: secretariat@applecongress.org